Medtech titan Edwards Lifesciences (NYSE:EW) today named Scott Ullem its new chief financial officer, replacing retiring CFO Thomas Abate. Ullem will take on the role at the start of 2014.
Abate in May announced his intention to step down, having held Edwards’ CFO title since 2006, prior to which he spent 6 years as the company’s vice president & controller. He had agreed to step down after a replacement was found.
New CFO Ullem comes from Bemis Company, a supplier of packaging and sensitive materials, where he’d been president and CFO since 2010, according to a press release.
"After an extensive search, and discussions with many qualified candidates, we are very pleased that Scott has agreed to join Edwards at the start of 2014. Scott has nearly 25 years of broad financial experience, proven leadership skills and a successful record as CFO of a global public company," Edwards chairman & CEO Michael Mussallem said in prepared remarks. "We are confident he will serve as a valuable and passionate partner as our company continues its growth and expands its leadership in innovative technologies for structural heart disease and critical care patients in need."
EW stock didn’t move much on the news today, with shares up 0.6% to $65.24 as of about 12:35 p.m.